Clinical Trial Update: Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and efficacy of ticagrelor to maintain patency of arteriovenous fistulae for hemodialysis; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Vascular Access Patency

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Virginia | Conditions: End Stage Renal Disease, Vascular Access Patency | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-08